Selective Bacterial Targeting and Infection-Triggered Release of Antibiotic Colistin Conjugates.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractIn order to render potent, but toxic antibiotics more selective, we have explored a novel conjugation strategy that includes drug accumulation followed by infection-triggered release of the drug. Bacterial targeting was achieved using a modified fragment of the human antimicrobial peptide ubiquicidin, as demonstrated by fluorophore-tagged variants. To limit the release of the effector colistin only to infection-related situations, we introduced a linker that was cleaved by neutrophil elastase (NE), an enzyme secreted by neutrophil granulocytes at infection sites. The linker carried an optimized sequence of amino acids that was required to assure sufficient cleavage efficiency. The antibacterial activity of five regioisomeric conjugates prepared by total synthesis was masked, but was released upon exposure to recombinant NE when the linker was attached to amino acids at the 1- or the 3-position of colistin. A proof-of-concept was achieved in co-cultures of primary human neutrophils and Escherichia coli that induced the secretion of NE, the release of free colistin, and an antibacterial efficacy that was equal to that of free colistin.
CitationAngew Chem Int Ed Engl. 2021 Aug 9;60(33):17989-17997. doi: 10.1002/anie.202104921. Epub 2021 Jul 5.
AffiliationHZI,Helmholtz-Zentrum für Infektionsforschung GmbH, Inhoffenstr. 7,38124 Braunschweig, Germany.
The following license files are associated with this item:
- Creative Commons
- Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
- Authors: Hansen AM, Bonke G, Hogendorf WFJ, Björkling F, Nielsen J, Kongstad KT, Zabicka D, Tomczak M, Urbas M, Nielsen PE, Franzyk H
- Issue date: 2019 Apr 15
- Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
- Authors: Lee JY, Choi MJ, Choi HJ, Ko KS
- Issue date: 2016 Jan
- Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.
- Authors: Yokota SI, Hakamada H, Yamamoto S, Sato T, Shiraishi T, Shinagawa M, Takahashi S
- Issue date: 2018 Jun
- Use of WalkAway MicroScan system colistin well when determining the susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii recent clinical isolates.
- Authors: Borrego-Jiménez J, Soria-Segarra C, Moldovan TD, Navarro-Marí JM, Gutiérrez-Fernández J
- Issue date: 2020 Feb
- Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media.
- Authors: Matzneller P, Strommer S, Österreicher Z, Mitteregger D, Zeitlinger M
- Issue date: 2015 Oct